Profile number 104644
06/05/2022 Date added
Located in
Also interesting for this region (s)
All of the country
Sector
Engineering
Type of company
Medical devices industry
Legal entity
Foreign legal entity
Type of transaction
Shares
Life phase enterprise
Growing
Employees in FTE
5 - 10
Type of buyer
Strategic acquisition
Turnover last financial year
Confidential
Asking price
> 5.000.000
Earnings before taxes
Confidential
The company was founded over 10 years ago and is a diagnostic ultrasound company that exploits the information present in ultrasound signals to the extent that it sets new standards in imaging and diagnosis of tendons, ligaments and muscles.
A diagnostic ultrasound company that exploits the information present in ultrasound signals to the extent that it sets new standards in imaging and diagnosis of tendons, ligaments and muscles.
The company has developed an imaging modality that gives true insight in the ultra-structure (time efficiently and at a fraction of the cost when for example compared with a MRI-scan). It is operator independent, highly reproduceable and sensitive to detect even the onset of injuries.
At this moment the company has already realized sales and has an installed base of appr. 80 systems spread all over the world.
The company's customers are in both human and veterinary healthcare.
Currently the company sells appr. 10-15 systems annually with a gross margin varying from 65% to 70%.
So far ultrasound and MRI are the only imaging techniques available. However, these modalities lack resolution or sensitivity and specificity and are extremely operator dependent.
The technique developed by the company gives true insight in the ultra-structure of the tendons, ligaments and muscle at a fraction of the cost when for example compared with a MRI-scan.
Furthermore, this technique is far less time- consuming while scans can be made within only a couple of minutes and subsequent analysis and interpretation within another couple of minutes.
The age of some of the shareholders in combination with the absence of any successor, triggered them to seriously consider the possibilities of selling their shares in the company to a third (strategic) party.
In addition to this, the shareholders want to guarantee the continuity of-, and the accumulated knowledge within the company, thus preserving the developed system/product and it’s huge potential for the market.
The moment the company becomes part of a strategic party with substantial sales- and marketing power all over the world sales can undoubtedly be increased to a couple of hundred systems per year.